Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Valdecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is a selective cyclooxygenase-2 inhibitor. It was patented in 1995.
The analysis highlights Applications, Art, Regions and Companies as prominent areas in the source structure around Valdecoxib.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
A focused starting point derived from the topic graph, ranked independently of the source article order.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Valdecoxib shows recurring relationship patterns in the source. For example, Valdecoxib → AU: S4 (Prescription only), BR: Class C1 (Other controlled substances), Withdrawn in U.S., EU, Canada and parts of Asia Another extracted example is Valdecoxib → FDA, In, United States. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
bextra pfizer drug fda arthritis company united states settlement largest billion 2005 market 2009 prescription american risk adverse fine anti-inflammatory
TTTA extracted 33 structured relationships around Valdecoxib. Examples in this analysis include Valdecoxib → 3D model (JSmol) → Interactive image and Valdecoxib → ATC code → M01AH03 (WHO). The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Valdecoxib | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Valdecoxib | ATC code | M01AH03 (WHO) | 1.00 | infobox |
| Valdecoxib | Bioavailability | 83% | 1.00 | infobox |
| Valdecoxib | CAS Number | 181695-72-7 N | 1.00 | infobox |
| Valdecoxib | ChEBI | CHEBI:63634 N | 1.00 | infobox |
| Valdecoxib | ChEMBL | ChEMBL865 Y | 1.00 | infobox |
| Valdecoxib | ChemSpider | 106796 Y | 1.00 | infobox |
| Valdecoxib | CompTox Dashboard (EPA) | DTXSID6044226 | 1.00 | infobox |
| Valdecoxib | DrugBank | DB00580 Y | 1.00 | infobox |
| Valdecoxib | ECHA InfoCard | 100.229.918 | 1.00 | infobox |
| Valdecoxib | Elimination half-life | 8 to 11 hours | 1.00 | infobox |
| Valdecoxib | Excretion | Renal | 1.00 | infobox |
| Valdecoxib | Formula | C16H14N2O3S | 1.00 | infobox |
| Valdecoxib | IUPHAR/BPS | 2894 | 1.00 | infobox |
| Valdecoxib | KEGG | D02709 Y | 1.00 | infobox |
| Valdecoxib | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Valdecoxib | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Valdecoxib | Legal status | Withdrawn in U.S., EU, Canada and parts of Asia | 1.00 | infobox |
| Valdecoxib | Metabolism | Hepatic (CYP3A4 and 2C9 involved) | 1.00 | infobox |
| Valdecoxib | Molar mass | 314.36 g·mol−1 | 1.00 | infobox |
| Valdecoxib | Pregnancy category | AU: C | 1.00 | infobox |
| Valdecoxib | Pregnancy category | May cause premature closure of the ductus arteriosus | 1.00 | infobox |
| Valdecoxib | Protein binding | 98% | 1.00 | infobox |
| Valdecoxib | PubChem CID | 119607 | 1.00 | infobox |
| Valdecoxib | Routes of administration | Oral | 1.00 | infobox |
| Valdecoxib | Trade names | Bextra | 1.00 | infobox |
| Valdecoxib | UNII | 2919279Q3W | 1.00 | infobox |
| Valdecoxib | is a | nonsteroidal anti-inflammatory drug | 0.90 | text |
The concept neighborhoods around Valdecoxib bring nearby vocabulary together. In this analysis, examples include Methods, Asia and Canada. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Valdecoxib, one of the stronger structural bridges in this analysis connects Valdecoxib with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Valdecoxib to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications, Art, Regions & Companies, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Valdecoxib · EN edition · Analysis: TopicsToTalkAbout